Transforming growth factor-β inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response

International Immunology

Volumn 15, Issue 12, 2003, Pages 1495-1504

  Tiemessen, Machteld M ^a   Kunzmann, Steffen ^b   Schmidt Weber, Carsten B ^b   Garssen, Johan ^c   Bruijnzeel Koomen, Carla A F M ^a   Knol, Edward F ^a   Van Hoffen, Els ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c NUMICO RESEARCH   (Netherlands)

Author keywords

CD25; IL 10; Immunosuppression; Smad protein; Tolerance

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CYTOKINE; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SIGNAL PEPTIDE; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL ANCHORAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME REGULATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MITOSIS RATE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; T LYMPHOCYTE;

ANIMALS; ANNEXIN A5; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; B-LYMPHOCYTES; CARRIER PROTEINS; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CHILD, PRESCHOOL; CLONE CELLS; COCULTURE TECHNIQUES; CYTOKINES; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MILK HYPERSENSITIVITY; MILK PROTEINS; MITOCHONDRIAL PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN PRECURSORS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0347407823     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg147     Document Type: Article

References (41)

1. Friedman, A. and Weiner, H. L. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl Acad. Sci. USA 91:6688.
2. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
3. MacDonald, T. T. 1998. T cell immunity to oral allergens. Curr. Opin. Immunol. 10:620.
4. Schmidt-Weber, C. B. and Blaser, K. 2002. T-cell tolerance in allergic response. Allergy 57:762.
5. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. and Levings, M. K. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68.
6. h3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3:947.
7. Letterio, J. J. and Roberts, A. B. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:137.
8. Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A. and Thorbecke, G. J. 1991. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl Acad. Sci. USA 88:2918.
9. Wallick, S. C., Figari, I. S., Morris, R. E., Levinson, A. D. and Palladino, M. A. 1990. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J. Exp. Med. 172:1777.
10. Miura, S., Takeshita, T., Asao, H., Kimura, Y., Murata, K., Sasaki, Y., Hanal, J. I., Beppu, H., Tsukazaki, T., Wrana, J. L., Miyazono, K. and Sugamura, K. 2000. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol. Cell Biol. 20:9346.
11. Kunzmann, S., Wohlfahrt, J. G., Itoh, S., Asao, H., Komada, M., Akdis, C. A., Blaser, K. and Schmidt-Weber, C. B. 2003. SARA and Hgs attenuate susceptibility to TGF-β1-mediated T cell suppression. FASEB J. 17:194.
12. Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169.
13. Nakao, A., Miike, S., Hatano, M., Okumura, K., Tokuhisa, T., Ra, C. and Iwamoto, I. 2000. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J. Exp. Med. 192:151.
14. Monteleone, G., Kumberova, A., Croft, N. M., McKenzie, C., Steer, H. W. and MacDonald, T. T. 2001. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108:601.
15. Gorelik, L. and Flavell, R. A. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171.
16. Lucas, P. J., Kim, S. J., Melby, S. J. and Gress, R. E. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J. Exp. Med. 191:1187.
17. Hahm, K. B., Im, Y. H., Parks, T. W., Park, S. H., Markowitz, S., Jung, H. Y., Green, J. and Kim, S. J. 2001. Loss of transforming growth factor beta signaling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49:190.
18. Cottrez, F. and Groux, H. 2001. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J. Immunol. 167:773.
19. h2 T cells. Eur. J. Immunol. 30:2101.
20. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B. and Fauci, A. S. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
21. Ahuja, S. S., Paliogianni, F., Yamada, H., Balow, J. E. and Boumpas, D. T. 1993. Effect of transforming growth factor-beta on early and late activation events in human T cells. J. Immunol. 150:3109.
22. H2 cytokines. J. Allergy Clin. Immunol. 106:1155.
23. Yssel, H., de Vries, J. E., Koken, M., Van Blitterswijk, W. and Spits, H. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72:219.
24. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285.
25. Gorelik, L. and Flavell, R. A. 2002. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2:46.
26. Arkwright, P. D., Chase, J. M., Babbage, S., Pravica, V., David, T. J. and Hutchinson, I. V. 2001. Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J. Allergy Clin. Immunol. 108:281.
27. Andersson, P. O., Stockelberg, D., Jacobsson, S. and Wadenvik, H. 2000. A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann. Hematol 79:507.
28. Horwitz, D. A., Gray, J. D. and Zheng, S. G. 2002. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. 4:241.
29. Hirayama, Y., Sakamaki, S., Matsunaga, T., Kuroda, H., Kusakabe, T., Akiyama, T., Kato, J., Kogawa, K., Koyama, R., Nagai, T., Ohta, H. and Niitsu, Y. 2002. Granulocyte-colony stimulating factor enhances the expression of transforming growth factor-beta mRNA in CD4-positive peripheral blood lymphocytes in the donors for allogeneic peripheral blood stem cell transplantation. Am. J. Hematol. 69:138.
30. + T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105:61.
31. + T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Am. J. Respir. Cell Mol. Biol. 21:268.
32. h2-induced cutaneous inflammatory responses to OVA by different mechanisms. J. Immunol. 167:3661.
33. Cerwenka, A., Kovar, H., Majdic, O. and Holter, W. 1996. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J. Immunol. 156:459.
34. Zhang, X., Giangreco, L., Broome, H. E., Dargan, C. M. and Swain, S. L. 1995. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182:699.
35. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y. and Wang, X. F. 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad. Sci. USA 92:5545.
36. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. and Koff, A. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
37. Brabletz, T., Pfeuffer, I., Schorr, E., Siebelt, F., Wirth, T. and Serfling, E. 1993. Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell. Biol. 13:1155.
38. Sillett, H. K., Cruickshank, S. M., Southgate, J. and Trejdosiewicz, L. K. 2001. Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells. Immunology 102:310.
39. Sun, J., Dirden-Kramer, B., Ito, K., Ernst, P. B. and Van Houten, N. 1999. Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162:5868.
40. Takeuchi, M., Alard, P. and Streilein, J. W. 1998. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589.
41. Schramm, C., Herz, U., Podlech, J., Protschka, M., Finotto, S., Reddehase, M. J., Kohler, H., Galle, P. R., Lohse, A. W. and Blessing, M. 2003. TGF-Beta regulates airway responses via T cells. J. Immunol. 170:1313.